Pharmacologic inducers of the uric acid exporter ABCG2 as potential drugs for treatment of gouty arthritis
Uric acid is the end product of purine catabolism and its plasma levels are maintained below its maximum solubility in water (6-7 mg/dl). The plasma levels are tightly regulated as the balance between the rate of production and the rate of excretion, the latter occurring in urine (kidney), bile (liv...
Saved in:
Main Authors: | Bojana Ristic (Author), Mohd Omar Faruk Sikder (Author), Yangzom D. Bhutia (Author), Vadivel Ganapathy (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The amino acid transporter SLC6A14 in cancer and its potential use in chemotherapy
by: Yangzom D. Bhutia, et al.
Published: (2014) -
Gouty arthritis and kidney function outcomes and serum uric acid level variations in obese patients following bariatric surgery
by: Mona G. Balata, et al.
Published: (2022) -
SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine-Glycine-One-Carbon Pathways in Cancer
by: Tyler Sniegowski, et al.
Published: (2021) -
Septic arthritis with concomitant gouty arthritis
by: Govind S Shiddapur, et al.
Published: (2015) -
Non-Pharmacological Pain Management In Patient With Gouty Arthritis: A Narrative Review
by: Novia Yulianti, et al.
Published: (2023)